Midazolam Continuous Infusion Protocol After Lorazepam for Status Epilepticus
For refractory status epilepticus after lorazepam, initiate midazolam with a loading dose of 0.15-0.20 mg/kg IV, followed by continuous infusion starting at 0.06 mg/kg/hr (1 mcg/kg/min), titrating upward by 0.06 mg/kg/hr increments every 15 minutes until seizures stop, up to a maximum of 0.3 mg/kg/hr (5 mcg/kg/min). 1
Dosing Protocol
Loading Dose
- 0.15-0.20 mg/kg IV administered over 2-3 minutes 1
- This establishes therapeutic levels rapidly
Continuous Infusion
Starting rate: 0.06 mg/kg/hr (1 mcg/kg/min) 1
Titration strategy:
- Increase by 0.06 mg/kg/hr increments every 15 minutes until seizures cease 1
- Maximum rate: 0.3 mg/kg/hr (5 mcg/kg/min) 1
Evidence-Based Rationale
The pediatric emergency guidelines provide the most specific dosing protocol for refractory status epilepticus. Recent research demonstrates that early, aggressive midazolam dosing (targeting 0.12-0.30 mg/kg/hr within the first 15 minutes) achieves seizure control in 92% of patients 2. Higher-dose protocols (up to 1.0 mg/kg/hr) are associated with lower withdrawal seizures (15% vs 64%) and reduced mortality compared to traditional lower-dose approaches 3.
Critical Safety Considerations
Respiratory Management
- Prepare for intubation before starting infusion 1
- Apnea risk increases significantly when midazolam follows lorazepam 1
- Have airway equipment immediately available 4
- Continuous oxygen saturation monitoring is mandatory 1
Hemodynamic Monitoring
- Hypotension occurs more frequently at higher infusion rates but is manageable and not associated with worse outcomes 3
- Monitor blood pressure continuously
- Have vasopressor support available if needed
Common Pitfall
Do NOT use flumazenil to reverse respiratory depression - it will reverse anticonvulsant effects and precipitate seizure recurrence 1
Alternative Approach for Non-Refractory Cases
If seizures persist after lorazepam but the patient is not in established refractory status epilepticus, consider second-line agents before midazolam infusion:
- Fosphenytoin, levetiracetam, or valproate have similar efficacy (all ~70-88% effective) 5, 6
- These avoid the need for continuous infusion and intubation
However, midazolam infusion remains the definitive treatment for truly refractory status epilepticus that fails benzodiazepines and a second-line agent 5.
Practical Implementation
Preparation checklist:
- Secure IV access
- Intubation equipment at bedside
- Continuous EEG monitoring if available (clinical observation acceptable if EEG unavailable) 1
- Vasopressor support available
- Dilute midazolam 5 mg/mL to 0.5 mg/mL concentration for infusion 7
Infusion management:
- Titrate every 15 minutes based on clinical/EEG response 1
- Once seizures controlled, maintain infusion for 12-24 hours
- Taper by 10-25% every few hours to find minimum effective rate 7
- Early initiation (within 15 minutes of seizure onset) significantly improves outcomes - reduces time to seizure control and infusion duration 8, 9